publication venue for
- Comment on: Influence of prior antibiotic use on risk of rheumatoid arthritis: case–control study in general practice. Reply. 60:e150-e150. 2021
- Contextualizing temporal arterial magnetic resonance angiography in the diagnosis of giant cell arteritis: a retrospective cohort study 2021
- Response to placebo in non-renal, non-neuropsychiatric systemic lupus erythematosus: a systematic review and pooled analysis. 60:73-80. 2021
- Long-term outcomes and disease course of children with juvenile idiopathic arthritis in the ReACCh-Out cohort: a two-centre experience. 59:3727-3730. 2020
- Corrigendum to: Incidence and prevalence of giant cell arteritis in Ontario, Canada. 59:3584-3584. 2020
- Incidence and prevalence of giant cell arteritis in Ontario, Canada. 59:3250-3258. 2020
- A new Canadian inception cohort for juvenile idiopathic arthritis: The Canadian Alliance of Pediatric Rheumatology Investigators Registry. 59:2796-2805. 2020
- Influence of prior antibiotic use on risk of rheumatoid arthritis: case control study in general practice. 59:1281-1287. 2020
- Changes in skin score in early diffuse cutaneous systemic sclerosis are associated with changes in global disease severity. 59:398-406. 2020
- Severe gastrointestinal disease in very early systemic sclerosis is associated with early mortality. 58:636-644. 2019
- Renal relapse in antineutrophil cytoplasmic autoantibody-associated vasculitis: unpredictable, but predictive of renal outcome. 58:103-109. 2019
- Treatment of small intestinal bacterial overgrowth in systemic sclerosis: a systematic review. 57:1802-1811. 2018
- The Scleroderma Patient-Centered Intervention Network Cohort: baseline clinical features and comparison with other large scleroderma cohorts. 57:1623-1631. 2018
- Evaluation of damage in giant cell arteritis. 57:322-328. 2018
- Evaluating the design and reporting of pragmatic trials in osteoarthritis research. 57:59-63. 2018
- Predictive value of European Scleroderma Group Activity Index in an early scleroderma cohort. 56:1111-1122. 2017
- The effect of rheumatoid arthritis–associated autoantibodies on the incidence of cardiovascular events in a large inception cohort of early inflammatory arthritis. 56:kew474-kew474. 2017
- Clinical correlates of faecal incontinence in systemic sclerosis: identifying therapeutic avenues. 56:kew441-kew441. 2017
- BSR and BHPR guideline for the treatment of axial spondyloarthritis (including ankylosing spondylitis) with biologics. 56:313-316. 2017
- Calcinosis is associated with digital ischaemia in systemic sclerosis—a longitudinal study. 55:2148-2155. 2016
- Self-reported comorbidity is common in early inflammatory arthritis and associated with poorer function and worse arthritis disease outcomes: results from the Canadian Early Arthritis Cohort. 55:1751-1762. 2016
- Value of commonly measured laboratory tests as biomarkers of disease activity and predictors of relapse in eosinophilic granulomatosis with polyangiitis. 54:1351-1359. 2015
- What drives the comparative effectiveness of biologics vs methotrexate in rheumatoid arthritis? Meta-regression and graphical inspection of suspected clinical factors. 53:1264-1273. 2014
- Are there differences between young- and older-onset early inflammatory arthritis and do these impact outcomes? An analysis from the CATCH cohort. 53:1075-1086. 2014
- The prevalence of vertebral fracture on vertebral fracture assessment imaging in a large cohort of patients with rheumatoid arthritis. 53:821-827. 2014
- Unilateral vs bilateral symptomatic knee osteoarthritis: associations between pain intensity and function. 52:2229-2237. 2013
- All-cause hospitalizations in systemic lupus erythematosus from a large Canadian referral centre. 52:905-909. 2013
- Increased production of IL-5 and dominant Th2-type response in airways of Churg–Strauss syndrome patients. 51:1887-1893. 2012
- von Willebrand factor antigen--a possible biomarker of disease activity in childhood central nervous system vasculitis?. 51:1838-1845. 2012
- Patients with psoriatic arthritis have worse quality of life than those with psoriasis alone. 51:571-576. 2012
- Association of myocardial infarctions with COX-2 inhibition may be related to immunomodulation towards a Th1 response resulting in atheromatous plaque instability: an evidence-based interpretation. 49:837-843. 2010
- Investigating the role of the interleukin-23/-17A axis in rheumatoid arthritis. 48:1581-1589. 2009
- Intrinsic pathway of apoptosis in peripheral blood eosinophils of Churg–Strauss syndrome. 48:1202-1207. 2009
- Reports of abnormal cervical cancer screening tests in systemic sclerosis. 48:149-151. 2009
- Quality of randomized clinical trials in juvenile idiopathic arthritis. 47:640-645. 2008
- Arthritis risk after acute bacterial gastroenteritis. 47:200-204. 2008
- Developing a disease activity tool for systemic-onset juvenile idiopathic arthritis by international consensus using the Delphi approach. 44:1574-1578. 2005
- What does ‘active disease’ mean? patient and parent perceptions of disease activity in the systemic arthritis form of juvenile idiopathic arthritis (SO-JIA). 44:796-799. 2005
- Acupuncture for the alleviation of lateral epicondyle pain: a systematic review. 43:1085-1090. 2004
- Safety of tacrolimus in patients with rheumatoid arthritis: long-term experience. 43:992-999. 2004
- Inaccuracy in the diagnosis of fibromyalgia syndrome: analysis of referrals. 42:263-267. 2003
- Stevens-Johnson syndrome in association with hydroxychloroquine treatment for rheumatoid arthritis. 41:A473-474. 2002
- Favourable outcome in 135 children with juvenile systemic sclerosis: results of a multi‐national survey. 39:556-559. 2000
- Characteristics of septic arthritis in human immunodeficiency virus- infected haemophiliacs versus other risk groups. 38:139-142. 1999
- Auranofin. 36:560-572. 1997
- Salmon calcitonin nasal spray in the prevention of corticosteroid- induced osteoporosis. 36:255-259. 1997
- SENSITIVITY AND SPECIFICITY OF DIFFERENT DIAGNOSTIC CRITERIA FOR BEHÇET'S DISEASE ACCORDING TO THE LATENT CLASS APPROACH. 34:932-935. 1995
- Successful Treatment of Gold-induced Aplastic Anaemia with Granulocyte Macrophage Colony Stimulating Factor. 31:428-429. 1992
- Prior Score Availability: Observations Using The WOMAC Osteoarthritis Index. 30:150-151. 1991
- INTERACTION OF IBUPROFEN AND WARFARIN ON PRIMARY HAEMOSTASIS. 28:46-49. 1989
- INCREASED INTESTINAL PERMEABILITY IN PATIENTS WITH RHEUMATOID ARTHRITIS: A SIDE-EFFECT OF ORAL NONSTEROIDAL ANTI-INFLAMMATORY DRUG THERAPY?. 26:103-107. 1987
- PUNCHED-CARD AID IN RHEUMATOLOGICAL DIAGNOSIS. 26:46-50. 1987
- Reinforcement of Bias in the Medical Literature: Nonsteroidal Anti-inflammatory Drugs and the Stomach—a Case in Poin. 26:231-232. 1987
- A CLINICAL SCORING SYSTEM FOR RISK STRATIFICATION OF GIANT CELL ARTERITIS 2019
- CLUSTER ANALYSIS TO EXPLORE CLINICAL SUBCLASSIFICATION OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (CHURG-STRAUSS) 2019
- FACTORS ASSOCIATED WITH DISEASE PROGRESSION IN PATIENTS WITH MYELOPEROXIDASE-ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-RELATED PULMONARY FIBROSIS 2019
- GENETIC EVIDENCE OF EOSINOPHIL NUMBER UNDERPINNING PR3-AAV AND PLAUSIBLE HOST GENETIC PREDISPOSITION TO MICROBIAL DRIVERS OF DISEASE 2019
- UTILIZATION OF CANADIAN HEALTHCARE ADMINISTRATIVE DATABASES TO ACCURATELY IDENTIFY CASES OF ANCA-ASSOCIATED VASCULITIS 2019
- A RANDOMIZED DOUBLE-BLIND TRIAL OF ABATACEPT AND GLUCOCORTICOIDS FOR THE TREATMENT OF TAKAYASU'S ARTERITIS 2017
- ARTERIAL LESIONS IN GIANT CELL ARTERITIS 2017
- DISCREPANCIES BETWEEN CLINICAL- AND IMAGING-BASED ASSESSMENTS OF DISEASE ACTIVITY IN TAKAYASU'S ARTERITIS 2017
- IDENTIFICATION OF FUNCTIONAL AND EXPRESSION POLYMORPHISMS ASSOCIATED WITH RISK FOR ANTI-NEUTROPHIL CYTOPLASMIC AUTOANTIBODY-ASSOCIATED VASCULITIS 2017
- LATE-ONSET RELAPSE IN PATIENTS WITH SYSTEMIC VASCULITIS 2017
- PATIENT REPORTED OUTCOMES AS PREDICTORS OF FLARES IN TAKAYASU ARTERITIS 2017
- PLASMA EXCHANGE AND GLUCOCORTICOID DOSING IN THE TREATMENT OF ANTI-NEUTROPHIL CYTOPLASM ANTIBODY ASSOCIATED VASCULITIS: BASELINE CHARACTERISTICS OF A RANDOMIZED CONTROLLED TRIAL (PEXIVAS) 2017
- PREVALENCE OF IMMUNOFLUORESCENT DEPOSITS IN ANCA ASSOCIATED VASCULITIS 2017
- SPUTUM ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA) IN EOSINOPHILIC GRANULAMATOSIS AND POLYANGIITIS (EGPA) 2017
- TWO INTERNATIONAL MULTIREGIONAL INVESTIGATOR INITIATED CLINICAL TRIALS ON VASCULITIS: COLLABORATION WITH EUVAS, VCRC AND NATIONWIDE VASCULITIS STUDY GROUPS OF JAPAN 2017
- URINARY EPIDERMAL GROWTH FACTOR AS A BIOMARKER OF RENAL INVOLVEMENT IN ANCA-ASSOCIATED VASCULITIS 2017
- UTILITY OF MEASUREMENTS OF URINARY SOLUBLE CD163 & MCP1 IN THE IDENTIFICATION OF SUBTLE RENAL FLARES IN ANCA VASCULITIS 2017
- Gout in paleopathology; The elusive nature of urate 2007